The Journal of Arthroplasty
Volume 16, Issue 3 , Pages 293-300 , April 2001

A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty

Received 31 August 2000 ,Accepted 16 October 2000.

References 

  1. Alexander G, Gustafson A, Wise G. Comparison of warfarin use in total knee replacement vs total hip replacement. Orthopedics. 1997;20:117
  2. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am. 1994;76:1174
  3. Ansari S, Warwick D, Ackroyd CE, et al.  Incidence of fatal pulmonary embolism after 1,390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases. J Arthroplasty. 1997;12:599
  4. Clarke MT, Green JS, Harper WM, et al.  Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis. J Bone Joint Surg Br. 1997;79:787
  5. Colwell CW, Spiro TE, Trowbridge AA, et al.  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective total knee arthroplasty. Clin Ortho. 1995;321:19–27
  6. Fauno P, Suomalainen O, Rehnberg V, et al.  Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 1994;76:1814
  7. Foley M, Maslack MM, Rothman RH, et al.  Pulmonary embolism after hip or knee replacement: postoperative changes on pulmonary scintigrams in asymptomatic patients. Radiology. 1989;172:481
  8. Francis CW, Pellegrini VD, Harris CM, et al.  Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee arthroplasty. Am J Med. 1989;87:61S
  9. Francis CW, Pellegrini VD, Stulberg BN, et al.  Prevention of venous thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1990;72:976
  10. Francis CW, Pellegrini VD, Harris CM, et al.  Prophylaxis of venous thrombosis following total hip and total knee replacement using antithrombin III and heparin. Semin Hematol. 1991;28:39
  11. Francis CW, Pellegrini VD, Leibert KM, et al.  Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement. Thromb Haemost. 1996;75:706
  12. Ginsberg JS, Nurmohamed MT, Gent M, et al.  Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery. Circulation. 1994;90:2385
  13. Haas SB, Insall JN, Scuderi GR, et al.  Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1990;72:27
  14. Hamulyak K, Lensing AW, van der Meer J, et al.  Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep venous thrombosis in elective hip and knee replacement?. Thromb Haemost. 1995;74:1428
  15. Heit JA, Berkowitz SD, Bona R, et al.  Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Thromb Haemost. 1997;77:32
  16. Hodge WA. Prevention of deep vein thrombosis after total knee arthroplasty. Clin Orthop. 1991;271:101–105
  17. Hui AC, Heras-Palou C, Dunn I, et al.  Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement. J Bone Joint Surg Br. 1996;78:550
  18. Hull R, Raskob G, Pineo G, et al.  A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep vein thrombosis after hip or knee implantation. N Engl J Med. 1993;329:1370
  19. Hull RD, Raskob GE, Pineo GF, et al.  Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. Arch Intern Med. 1997;157:298
  20. Kaempffe FA, Lifeso RM, Meinking C. Intermittent pneumatic compression versus coumadin: Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop. 1991;269:89–97
  21. Khaw FM, Moran CG, Pinder IM, et al.  The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation. J Bone Joint Surg Br. 1993;75:940
  22. Kim YH. The incidence of deep vein thrombosis after cementless and cemented knee replacement. J Bone Joint Surg Br. 1990;72:779
  23. Leclerc JR, Geerts WH, Desjardins L, et al.  A randomized trial of enoxaparin for the prevention of deep vein thrombosis after major knee surgery. Thromb Haemost. 1992;67:417
  24. Leclerc JR, Geerts WH, Desjardins L, et al.  Prevention of venous thromboembolism after knee arthroplasty. Ann Int Med. 1996;124:619
  25. Lemos MJ, Sutton D, Hozack WJ, et al.  Pulmonary embolism in total hip and knee arthroplasty. Clin Orthop. 1992;282:158–163
  26. Leutz DW, Stauffer ES. Color duplex Doppler ultrasound scanning for detection of deep venous thrombosis in total knee and hip arthroplasty patients: Incidence, location, and diagnostic accuracy compared with ascending venography. J Arthroplasty. 1994;9:543
  27. Levine MN, Gent M, Hirsh J, et al.  Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. Arch Int Med. 1996;156:851
  28. Lieberman JR, Sung R, Dorey F, et al.  Low-dose warfarin prophylaxis to prevent symptomatic pulmonary embolism after total knee arthroplasty. J Arthroplasty. 1997;12:180
  29. Lynch AF, Bourne RB, Rorabeck CH, et al.  Deep-vein thrombosis and continuous passive motion after total knee arthroplasty. J Bone Joint Surg Am. 1988;70:11
  30. Lynch JA, Baker PL, Polly RE, et al.  Mechanical measures in the prophylaxis of postoperative thromboembolism in total knee arthroplasty. Clin Orthop. 1990;260:24–29
  31. McGrath D, Dennyson WG, Rolland M. Death rate from pulmonary embolism. J R Coll Surg Edinb. 1996;41:265
  32. McKenna R, Galante J, Bachmann F, et al.  Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. BMJ. 1980;280:514
  33. Mohr DN, Silverstein MD, Ilstrup DM, et al.  Venous thromboembolism associated with hip and knee arthroplasty. Mayo Clin Proc. 1992;67:861
  34. Rader CP, Kramer C, Konig A, et al.  Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty. J Arthroplasty. 1998;13:180
  35. Sculco TP. Establishing a universal protocol for deep vein thrombosis following orthopedic surgery: total knee arthroplasty. Orthopedics. 1996;19:6
  36. Spiro TE, Fitzgerald RH, Trowbridge AA, et al.  Enoxaparin: a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery. Blood. 1994;10(suppl 1):246a
  37. Stringer MD, Steadman CA, Hedges AR, et al.  Deep vein thrombosis after elective knee surgery: an incidence study in 312 patients. J Bone Joint Surg Br. 1989;71:492
  38. Spiro TE, Fitzgerald RH, Trowbridge AA, et al.  Enoxaparin: a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery. (for the Enoxaparin Clinical Trial Group) Orthop Trans. 1995-96;19:78
  39. Stulberg BN, Insall JN, Williams GW, et al.  Deep-vein thrombosis following total knee replacement: an analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am. 1984;66:194
  40. Stulberg BN, Francis CW, Pellegrini VD, et al.  Antithrombin III/low-dose heparin in the prevention of deep-vein thrombosis after total knee arthroplasty. Clin Orthop. 1989;248:152–157
  41. Vanninen R, Manninen H, Soimakallio S, et al.  Asymptomatic deep venous thrombosis in the calf: accuracy and limitations of ultrasonography as a screening test after total knee arthroplasty. Br J Radiol. 1993;66:199
  42. Vresilovic EJ, Hozack WJ, Booth RE, et al.  Incidence of pulmonary embolism after total knee arthroplasty with low-dose coumadin prophylaxis. Clin Orthop. 1993;286:27–31
  43. Vresilovic EJ, Hozack WJ, Booth RE, et al.  Comparative risk of early postoperative pulmonary embolism after cemented total knee versus total hip arthroplasty with low-dose warfarin prophylaxis. Am J Knee Surg. 1996;9:2
  44. Warwick DJ, Whitehouse S. Symptomatic venous thromboembolism after total knee replacement. J Bone Joint Surg Br. 1997;79:780
  45. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1996;78:826
  46. Wilson NV, Das SK, Kakkar VV, et al.  Thrombo-embolic prophylaxis in total knee replacement: evaluation of the A-V Impulse system. J Bone Joint Surg Br. 1992;74:50
  47. DeFranzo AJ, Marasco P, Argenta LC. Warfarin-induced necrosis of the skin. Ann Plast Surg. 1995;34:203
  48. Eby CS. Warfarin-induced skin necrosis. Hematol Oncol Clin North Am. 1993;7:1291
  49. Essex DW, Wynn SS, Jin DK. Late-onset warfarin-induced skin necrosis: case report. Am J Hematol. 1998;57:233
  50. Sutherland CJ, Schurman JR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop. 1987;219:158–162
  51. Warkentin TE, Sikov WM, Lillicrap DP. Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia. Am J Hematol. 1999;62:44
  52. Bleasel JF, Rasko JE, Rickard KA, et al.  Acute adrenal insufficiency secondary to heparin-induced thrombocytopenia-thrombosis syndrome. Med J Aust. 1992;157:192
  53. Januzzi JL, Jang IK. Heparin induced thrombocytopenia. J Thromb Thrombol. 1999;7:259
  54. Kelton JG. The clinical management of heparin-induced thrombocytopenia. Semin Hematol. 1999;36:17
  55. Ortel TL, Chong BH. New treatment options for heparin-induced thrombocytopenia. Semin Hematol. 1998;35:26
  56. Patterson BM, Marchand R, Ranawat C. Complications of heparin therapy after total joint arthroplasty. J Bone Joint Surg Am. 1989;71:1130
  57. Plath J, Schulze R, Barz D, et al.  Necrotizing skin lesions induced by low-molecular-weight heparin after total knee arthroplasty. Arch Orthop Trauma Surg. 1997;116:443
  58. Raible MD. Hematologic complications of heparin-induced thrombocytopenia. Semin Thromb Hemost. 1999;25:17
  59. Walenga JM, Bick RL. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Med Clin North Am. 1998;82:635
  60. Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol. 1998;35:9
  61. Warkentin TE. Heparin-induced thrombocytopenia: a ten-year retrospective. Ann Rev Med. 1999;50:129
  62. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. New York: Clarendon Press,; 1994;
  63. Howard AW, Aaron SD. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty: a meta-analysis of randomized trials. Thromb Haemost. 1998;79:902
  64. Westrich GH. The role of mechanical and other adjuncts. Am J Knee Surg. 1999;12:64
  65. Wilson NV, Das SK, Kakkar VV, et al.  Thrombo-embolic prophylaxis in total knee replacement: evaluation of the A-V Impulse system. J Bone Joint Surg Br. 1992;74:50
  66. Fitzgerald RH. Preventing DVT following total knee replacement: a review of recent clinical trials. Orthopedics. 1995;18(suppl):10
  67. Freedman KB, Brookenthal KR, Fitzgerald RH, et al.  A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000;82:929

☆ No benefits or funds were received in support of this study.

☆☆ Reprint requests: K. R. Brookenthal, MD, Department of Orthopaedic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104. E-mail: keithbrookenthal@yahoo.com

PII: S0883-5403(01)55811-8

doi: 10.1054/arth.2001.21499

The Journal of Arthroplasty
Volume 16, Issue 3 , Pages 293-300 , April 2001

Article Tools